2024-04-02T17:41:37-05:00 2023-12-31 990 2023-01-01 834634227 LYDIAN ACCELERATOR % Rohan Seth LYDI 6503845866 548 MARKET ST Ste PMB 38841 San Francisco CA 94104 ROHAN SETH President 6503845866 2024-04-02 ROHAN SETH 999009999 false 0 AAL2 IAL1 2023 2023-04-26 12:10:37Z ROHAN SETH 548 MARKET ST Ste PMB 38841 San Francisco CA 94104 257301 false X WWW.LYDIANACCELERATOR.ORG X 2019 CA Our mission is to bring an end to the long tail of genetic disease 5 5 0 5 0 18723 26259 0 32615 231042 0 51338 257301 501171 44400 0 0 0 0 55252 156976 556423 201376 -505085 55925 4741496 4797421 0 4741496 4797421 To invest in scientific and translational research of personalized genetic treatments for children impacted by severe genetic disease. false false 190455 44400 CONTINUED A DRUG DISCOVERY PROGRAM FOR A NOVEL ALLELE SELECTIVE ANTISENSE OLIGONUCLEOTIDE MOLECULE TO KNOCKDOWN THE MUTANT KCNQ2 CAUSING DEVELOPMENT AND EPILEPTIC ENCEPHALOPATHY. 190455 true true false false false false false false false false false false false false false false false false false false false false false false false false false true false false false false false false false false false false false false false false false false false false false true 0 0 true 0 false false false false false false false false false false X 5 5 true false false false false false false true true false false true true true true false false false false false CA X ROHAN SETH 6503845866 548 MARKET ST Ste PMB 38841 San Francisco CA 94104 X ROHAN SETH President 25.00 X X 0 0 0 JENNIFER SETH Secretary 10.00 X X 0 0 0 CINNAMON CHU Treasurer 1.000 X X 0 0 0 MICHAEL CHU Board Member 0.500 X 0 0 0 ROHAN DANG Board Member 0.500 X 0 0 0 false false false 25444 815 26259 231042 231042 0 257301 231042 44400 44400 7441 7441 2691 2691 97 97 692 692 5114 5114 Research Services 140941 140941 201376 190455 10921 0 29490 2228 4712006 4795193 4741496 4797421 0 0 X 4741496 4797421 4741496 4797421 4741496 4797421 55925 X false false false X 2118302 404785 4972471 18723 26259 7540540 2118302 404785 4972471 18723 26259 7540540 7540540 4521 6902 91 32605 231042 275161 7815701 X 0.00000 Part II 2019 was 4/26/19-12/31/19 due to first year in exis RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false CHILDREN'S HOSPITAL CORPOR 300 Longwood Ave Boston MA 02115 042774441 501C3 44400 0 ASO RESEARCH 2 0 PART I LINE 2 GRANTEES ARE REQUIRED TO PROVIDE REPORTS OF WORK AND RESULTS FOR EACH PART I LINE 2 MILESTONE INCLUDING SUMMARY OF RESEARCH AND BREAKDOWN OF COSTS BOTH DIRECT PART I LINE 2 AND PASSTHROUGH BIWEEKLY EMAIL OR VIDEO CONFERENCE CHECKINS ARE ALSO PART I LINE 2 HIGHLY RECOMMENDED Part VI Line 2 ROHAN SETH AND JENNIFER SETH HAVE A FAMILY RELATIONSHIP. Part VI Line 2 MICHAEL CHU AND CINNAMON CHU HAVE A FAMILY RELATIONSHIP. Part VI Line 11b FORM 990 IS REVIEWED BY ALL BOARD MEMBERS PRIOR TO FILING. Part VI Line 12c See above Part VI Line 19 See above Part VI, Sec B, Line 12C: THE CONFLICT OF INTEREST POLICY COVERS DIRECTORS, PRINCIPAL OFFICERS, AND Part VI, Sec B, Line 12C: MEMBERS OF A COMMITTEE WITH GOVERNING BOARD DELEGATED POWERS, WHO HAVE A Part VI, Sec B, Line 12C: DIRECT OR INDIRECT FINANCIAL INTEREST. IN CONNECTION WITH ANY ACTUAL OR Part VI, Sec B, Line 12C: POSSIBLE CONFLICT OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE Part VI, Sec B, Line 12C: EXISTENCE OF THE FINANCIAL INTEREST AND BE GIVEN THE OPPORTUNITY TO Part VI, Sec B, Line 12C: DISCLOSE ALL MATERIAL FACTS TO THE DIRECTORS CONSIDERING THE PROPOSED Part VI, Sec B, Line 12C: TRANSACTION OR ARRANGEMENT. AFTER DISCLOSURE OF THE FINANCIAL INTEREST AND Part VI, Sec B, Line 12C: ALL MATERIAL FACTS, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, Part VI, Sec B, Line 12C: HE/SHE SHALL LEAVE THE BOARD MEETING WHILE THE DETERMINATION OF A CONFLICT Part VI, Sec B, Line 12C: OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD MEMBERS SHALL Part VI, Sec B, Line 12C: DECIDE IF A CONFLICT OF INTEREST EXISTS. THE CHAIR OF THE BOARD SHALL, IF Part VI, Sec B, Line 12C: APPROPRIATE, APPOINT A DISINTERESTED PERSON OR GOVERNING COMMITTEE TO Part VI, Sec B, Line 12C: INVESTIGATE ALTERNATIVES TO THE PROPOSED TRANSACTION OR ARRANGEMENT. AFTER Part VI, Sec B, Line 12C: EXERCISING DUE DILIGENCE, THE BOARD SHALL DETERMINE WHETHER THE CORPORATION Part VI, Sec B, Line 12C: CAN OBTAIN WITH REASONABLE EFFORTS A MORE ADVANTAGEOUS TRANSACTION OR Part VI, Sec B, Line 12C: ARRANGEMENT FROM A PERSON OR ENTITY THAT WOULD NOT GIVE RISE TO A CONFLICT Part VI, Sec B, Line 12C: OF INTEREST. COVERED PERSONS ARE REQUIRED TO REVIEW AND CERTIFY COMPLIANCE Part VI, Sec B, Line 12C: WITH THE POLICY ON AN ANNUAL BASIS. FORM 990, PART VI, SECTION C, LINE 19: THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY AND FORM 990, PART VI, SECTION C, LINE 19: FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REQUEST WHEN FORM 990, PART VI, SECTION C, LINE 19: REQUIRED BY FEDERAL OR STATE LAW.